Global Large Volume Parenteral (LVP) Market Research Report 2020

Publisher Name :
Date: 21-Jan-2020
No. of pages: 122
Inquire Before Buying

The global Large Volume Parenteral (LVP) market is valued at 10710 million US$ in 2020 is expected to reach 19440 million US$ by the end of 2026, growing at a CAGR of 8.8% during 2021-2026.

This report focuses on Large Volume Parenteral (LVP) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Large Volume Parenteral (LVP) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, Middle East&Africa and India etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Large Volume Parenteral (LVP) market is segmented into

- Soft Bag LVP

- Plastic Bottle LVP

- Glass Bottle LVP

- In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.

Segment by Application

- Basic Infusion

- Therapeutic Infusion

- Nutritious Infusion

Global Large Volume Parenteral (LVP) Market: Regional Analysis

The Large Volume Parenteral (LVP) market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Large Volume Parenteral (LVP) market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Large Volume Parenteral (LVP) Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Large Volume Parenteral (LVP) market include:

- Baxter Healthcare

- Kelun Pharma

- B. Braun

- Fresenius

- Teva Pharmaceutical Industries

- Pfizer (Hospira)

- Ostuka Pharmaceutical

- CR Double-Crane

- Pisa

- Huaren

- Patheon

- Aspen Holdings

- Beximco Pharma

- Cook Pharmica

- Albert David

- PSI Ltd

- Ozon Pharmaceuticals

- BAG Healthcare

- BML Parenteral Drugs

Global Large Volume Parenteral (LVP) Market Research Report 2020

Table of Contents
1 Large Volume Parenteral (LVP) Market Overview
1.1 Product Overview and Scope of Large Volume Parenteral (LVP)
1.2 Large Volume Parenteral (LVP) Segment by Type
1.2.1 Global Large Volume Parenteral (LVP) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Soft Bag LVP
1.2.3 Plastic Bottle LVP
1.2.4 Glass Bottle LVP
1.3 Large Volume Parenteral (LVP) Segment by Application
1.3.1 Large Volume Parenteral (LVP) Sales Comparison by Application: 2020 VS 2026
1.3.2 Basic Infusion
1.3.3 Therapeutic Infusion
1.3.4 Nutritious Infusion
1.4 Global Large Volume Parenteral (LVP) Market Size Estimates and Forecasts
1.4.1 Global Large Volume Parenteral (LVP) Revenue 2015-2026
1.4.2 Global Large Volume Parenteral (LVP) Sales 2015-2026
1.4.3 Large Volume Parenteral (LVP) Market Size by Region: 2020 Versus 2026
2 Global Large Volume Parenteral (LVP) Market Competition by Manufacturers
2.1 Global Large Volume Parenteral (LVP) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2015-2020)
2.3 Global Large Volume Parenteral (LVP) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Large Volume Parenteral (LVP) Manufacturing Sites, Area Served, Product Type
2.5 Large Volume Parenteral (LVP) Market Competitive Situation and Trends
2.5.1 Large Volume Parenteral (LVP) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Large Volume Parenteral (LVP) Players (Opinion Leaders)
3 Large Volume Parenteral (LVP) Retrospective Market Scenario by Region
3.1 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Large Volume Parenteral (LVP) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.3.1 North America Large Volume Parenteral (LVP) Sales by Country
3.3.2 North America Large Volume Parenteral (LVP) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.4.1 Europe Large Volume Parenteral (LVP) Sales by Country
3.4.2 Europe Large Volume Parenteral (LVP) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Large Volume Parenteral (LVP) Market Facts & Figures by Region
3.5.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region
3.5.2 Asia Pacific Large Volume Parenteral (LVP) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.6.1 Latin America Large Volume Parenteral (LVP) Sales by Country
3.6.2 Latin America Large Volume Parenteral (LVP) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Large Volume Parenteral (LVP) Market Facts & Figures by Country
3.7.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country
3.7.2 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Large Volume Parenteral (LVP) Historic Market Analysis by Type
4.1 Global Large Volume Parenteral (LVP) Sales Market Share by Type (2015-2020)
4.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Type (2015-2020)
4.3 Global Large Volume Parenteral (LVP) Price Market Share by Type (2015-2020)
4.4 Global Large Volume Parenteral (LVP) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Large Volume Parenteral (LVP) Historic Market Analysis by Application
5.1 Global Large Volume Parenteral (LVP) Sales Market Share by Application (2015-2020)
5.2 Global Large Volume Parenteral (LVP) Revenue Market Share by Application (2015-2020)
5.3 Global Large Volume Parenteral (LVP) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Large Volume Parenteral (LVP) Business
6.1 Baxter Healthcare
6.1.1 Corporation Information
6.1.2 Baxter Healthcare Description, Business Overview and Total Revenue
6.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Baxter Healthcare Products Offered
6.1.5 Baxter Healthcare Recent Development
6.2 Kelun Pharma
6.2.1 Kelun Pharma Large Volume Parenteral (LVP) Production Sites and Area Served
6.2.2 Kelun Pharma Description, Business Overview and Total Revenue
6.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Kelun Pharma Products Offered
6.2.5 Kelun Pharma Recent Development
6.3 B. Braun
6.3.1 B. Braun Large Volume Parenteral (LVP) Production Sites and Area Served
6.3.2 B. Braun Description, Business Overview and Total Revenue
6.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 B. Braun Products Offered
6.3.5 B. Braun Recent Development
6.4 Fresenius
6.4.1 Fresenius Large Volume Parenteral (LVP) Production Sites and Area Served
6.4.2 Fresenius Description, Business Overview and Total Revenue
6.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Fresenius Products Offered
6.4.5 Fresenius Recent Development
6.5 Teva Pharmaceutical Industries
6.5.1 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Production Sites and Area Served
6.5.2 Teva Pharmaceutical Industries Description, Business Overview and Total Revenue
6.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Teva Pharmaceutical Industries Products Offered
6.5.5 Teva Pharmaceutical Industries Recent Development
6.6 Pfizer (Hospira)
6.6.1 Pfizer (Hospira) Large Volume Parenteral (LVP) Production Sites and Area Served
6.6.2 Pfizer (Hospira) Description, Business Overview and Total Revenue
6.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Pfizer (Hospira) Products Offered
6.6.5 Pfizer (Hospira) Recent Development
6.7 Ostuka Pharmaceutical
6.6.1 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Production Sites and Area Served
6.6.2 Ostuka Pharmaceutical Description, Business Overview and Total Revenue
6.6.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Ostuka Pharmaceutical Products Offered
6.7.5 Ostuka Pharmaceutical Recent Development
6.8 CR Double-Crane
6.8.1 CR Double-Crane Large Volume Parenteral (LVP) Production Sites and Area Served
6.8.2 CR Double-Crane Description, Business Overview and Total Revenue
6.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 CR Double-Crane Products Offered
6.8.5 CR Double-Crane Recent Development
6.9 Pisa
6.9.1 Pisa Large Volume Parenteral (LVP) Production Sites and Area Served
6.9.2 Pisa Description, Business Overview and Total Revenue
6.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Pisa Products Offered
6.9.5 Pisa Recent Development
6.10 Huaren
6.10.1 Huaren Large Volume Parenteral (LVP) Production Sites and Area Served
6.10.2 Huaren Description, Business Overview and Total Revenue
6.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Huaren Products Offered
6.10.5 Huaren Recent Development
6.11 Patheon
6.11.1 Patheon Large Volume Parenteral (LVP) Production Sites and Area Served
6.11.2 Patheon Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.11.3 Patheon Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Patheon Products Offered
6.11.5 Patheon Recent Development
6.12 Aspen Holdings
6.12.1 Aspen Holdings Large Volume Parenteral (LVP) Production Sites and Area Served
6.12.2 Aspen Holdings Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.12.3 Aspen Holdings Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Aspen Holdings Products Offered
6.12.5 Aspen Holdings Recent Development
6.13 Beximco Pharma
6.13.1 Beximco Pharma Large Volume Parenteral (LVP) Production Sites and Area Served
6.13.2 Beximco Pharma Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.13.3 Beximco Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Beximco Pharma Products Offered
6.13.5 Beximco Pharma Recent Development
6.14 Cook Pharmica
6.14.1 Cook Pharmica Large Volume Parenteral (LVP) Production Sites and Area Served
6.14.2 Cook Pharmica Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.14.3 Cook Pharmica Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Cook Pharmica Products Offered
6.14.5 Cook Pharmica Recent Development
6.15 Albert David
6.15.1 Albert David Large Volume Parenteral (LVP) Production Sites and Area Served
6.15.2 Albert David Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.15.3 Albert David Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Albert David Products Offered
6.15.5 Albert David Recent Development
6.16 PSI Ltd
6.16.1 PSI Ltd Large Volume Parenteral (LVP) Production Sites and Area Served
6.16.2 PSI Ltd Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.16.3 PSI Ltd Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.16.4 PSI Ltd Products Offered
6.16.5 PSI Ltd Recent Development
6.17 Ozon Pharmaceuticals
6.17.1 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Production Sites and Area Served
6.17.2 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.17.3 Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Ozon Pharmaceuticals Products Offered
6.17.5 Ozon Pharmaceuticals Recent Development
6.18 BAG Healthcare
6.18.1 BAG Healthcare Large Volume Parenteral (LVP) Production Sites and Area Served
6.18.2 BAG Healthcare Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.18.3 BAG Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.18.4 BAG Healthcare Products Offered
6.18.5 BAG Healthcare Recent Development
6.19 BML Parenteral Drugs
6.19.1 BML Parenteral Drugs Large Volume Parenteral (LVP) Production Sites and Area Served
6.19.2 BML Parenteral Drugs Large Volume Parenteral (LVP) Description, Business Overview and Total Revenue
6.19.3 BML Parenteral Drugs Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2015-2020)
6.19.4 BML Parenteral Drugs Products Offered
6.19.5 BML Parenteral Drugs Recent Development
7 Large Volume Parenteral (LVP) Manufacturing Cost Analysis
7.1 Large Volume Parenteral (LVP) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Large Volume Parenteral (LVP)
7.4 Large Volume Parenteral (LVP) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Large Volume Parenteral (LVP) Distributors List
8.3 Large Volume Parenteral (LVP) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Large Volume Parenteral (LVP) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Type (2021-2026)
10.2 Large Volume Parenteral (LVP) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Application (2021-2026)
10.3 Large Volume Parenteral (LVP) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Large Volume Parenteral (LVP) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Large Volume Parenteral (LVP) by Region (2021-2026)
10.4 North America Large Volume Parenteral (LVP) Estimates and Projections (2021-2026)
10.5 Europe Large Volume Parenteral (LVP) Estimates and Projections (2021-2026)
10.6 Asia Pacific Large Volume Parenteral (LVP) Estimates and Projections (2021-2026)
10.7 Latin America Large Volume Parenteral (LVP) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Large Volume Parenteral (LVP) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Large Volume Parenteral (LVP) Sales (M Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Large Volume Parenteral (LVP) Sales (M Units) Comparison by Application: 2020 VS 2026
Table 3. Global Large Volume Parenteral (LVP) Market Size by Type (M Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Large Volume Parenteral (LVP) Manufacturers Covered in This Study
Table 5. Global Large Volume Parenteral (LVP) Sales (M Units) by Manufacturers (2015-2020)
Table 6. Global Large Volume Parenteral (LVP) Sales Share by Manufacturers (2015-2020)
Table 7. Global Large Volume Parenteral (LVP) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Large Volume Parenteral (LVP) Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Large Volume Parenteral (LVP) Sales Sites and Area Served
Table 11. Manufacturers Large Volume Parenteral (LVP) Product Types
Table 12. Global Large Volume Parenteral (LVP) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Large Volume Parenteral (LVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Large Volume Parenteral (LVP) as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Large Volume Parenteral (LVP) Players
Table 16. Global Large Volume Parenteral (LVP) Sales (M Units) by Region (2015-2020)
Table 17. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2015-2020)
Table 18. Global Large Volume Parenteral (LVP) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2015-2020)
Table 20. North America Large Volume Parenteral (LVP) Sales by Country (2015-2020) (M Units)
Table 21. North America Large Volume Parenteral (LVP) Sales Market Share by Country (2015-2020)
Table 22. North America Large Volume Parenteral (LVP) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Large Volume Parenteral (LVP) Revenue Market Share by Country (2015-2020)
Table 24. Europe Large Volume Parenteral (LVP) Sales by Country (2015-2020) (M Units)
Table 25. Europe Large Volume Parenteral (LVP) Sales Market Share by Country (2015-2020)
Table 26. Europe Large Volume Parenteral (LVP) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Large Volume Parenteral (LVP) Sales by Region (2015-2020) (M Units)
Table 29. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Large Volume Parenteral (LVP) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Large Volume Parenteral (LVP) Sales by Country (2015-2020) (M Units)
Table 33. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country (2015-2020)
Table 34. Latin America Large Volume Parenteral (LVP) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Large Volume Parenteral (LVP) Sales by Country (2015-2020) (M Units)
Table 37. Middle East and Africa Large Volume Parenteral (LVP) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Large Volume Parenteral (LVP) Revenue Market Share by Country (2015-2020)
Table 40. Global Large Volume Parenteral (LVP) Sales (M Units) by Type (2015-2020)
Table 41. Global Large Volume Parenteral (LVP) Sales Share by Type (2015-2020)
Table 42. Global Large Volume Parenteral (LVP) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Large Volume Parenteral (LVP) Revenue Share by Type (2015-2020)
Table 44. Global Large Volume Parenteral (LVP) Price (USD/Unit) by Type (2015-2020)
Table 45. Global Large Volume Parenteral (LVP) Sales (M Units) by Application (2015-2020)
Table 46. Global Large Volume Parenteral (LVP) Sales Market Share by Application (2015-2020)
Table 47. Global Large Volume Parenteral (LVP) Sales Growth Rate by Application (2015-2020)
Table 48. Baxter Healthcare Large Volume Parenteral (LVP) Corporation Information
Table 49. Baxter Healthcare Description and Business Overview
Table 50. Baxter Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Baxter Healthcare Main Product
Table 52. Baxter Healthcare Recent Development
Table 53. Kelun Pharma Large Volume Parenteral (LVP) Corporation Information
Table 54. Kelun Pharma Corporation Information
Table 55. Kelun Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Kelun Pharma Main Product
Table 57. Kelun Pharma Recent Development
Table 58. B. Braun Large Volume Parenteral (LVP) Corporation Information
Table 59. B. Braun Corporation Information
Table 60. B. Braun Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. B. Braun Main Product
Table 62. B. Braun Recent Development
Table 63. Fresenius Large Volume Parenteral (LVP) Corporation Information
Table 64. Fresenius Corporation Information
Table 65. Fresenius Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Fresenius Main Product
Table 67. Fresenius Recent Development
Table 68. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Corporation Information
Table 69. Teva Pharmaceutical Industries Corporation Information
Table 70. Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Teva Pharmaceutical Industries Main Product
Table 72. Teva Pharmaceutical Industries Recent Development
Table 73. Pfizer (Hospira) Large Volume Parenteral (LVP) Corporation Information
Table 74. Pfizer (Hospira) Corporation Information
Table 75. Pfizer (Hospira) Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Pfizer (Hospira) Main Product
Table 77. Pfizer (Hospira) Recent Development
Table 78. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Corporation Information
Table 79. Ostuka Pharmaceutical Corporation Information
Table 80. Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Ostuka Pharmaceutical Main Product
Table 82. Ostuka Pharmaceutical Recent Development
Table 83. CR Double-Crane Large Volume Parenteral (LVP) Corporation Information
Table 84. CR Double-Crane Corporation Information
Table 85. CR Double-Crane Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. CR Double-Crane Main Product
Table 87. CR Double-Crane Recent Development
Table 88. Pisa Large Volume Parenteral (LVP) Corporation Information
Table 89. Pisa Corporation Information
Table 90. Pisa Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Pisa Main Product
Table 92. Pisa Recent Development
Table 93. Huaren Large Volume Parenteral (LVP) Corporation Information
Table 94. Huaren Corporation Information
Table 95. Huaren Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Huaren Main Product
Table 97. Huaren Recent Development
Table 98. Patheon Large Volume Parenteral (LVP) Corporation Information
Table 99. Patheon Corporation Information
Table 100. Patheon Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Patheon Main Product
Table 102. Patheon Recent Development
Table 103. Aspen Holdings Large Volume Parenteral (LVP) Corporation Information
Table 104. Aspen Holdings Corporation Information
Table 105. Aspen Holdings Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Aspen Holdings Main Product
Table 107. Aspen Holdings Recent Development
Table 108. Beximco Pharma Large Volume Parenteral (LVP) Corporation Information
Table 109. Beximco Pharma Corporation Information
Table 110. Beximco Pharma Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Beximco Pharma Main Product
Table 112. Beximco Pharma Recent Development
Table 113. Cook Pharmica Large Volume Parenteral (LVP) Corporation Information
Table 114. Cook Pharmica Corporation Information
Table 115. Cook Pharmica Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Cook Pharmica Main Product
Table 117. Cook Pharmica Recent Development
Table 118. Albert David Large Volume Parenteral (LVP) Corporation Information
Table 119. Albert David Corporation Information
Table 120. Albert David Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Albert David Main Product
Table 122. Albert David Recent Development
Table 123. PSI Ltd Large Volume Parenteral (LVP) Corporation Information
Table 124. PSI Ltd Corporation Information
Table 125. PSI Ltd Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. PSI Ltd Main Product
Table 127. PSI Ltd Recent Development
Table 128. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Corporation Information
Table 129. Ozon Pharmaceuticals Corporation Information
Table 130. Ozon Pharmaceuticals Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Ozon Pharmaceuticals Main Product
Table 132. Ozon Pharmaceuticals Recent Development
Table 133. BAG Healthcare Large Volume Parenteral (LVP) Corporation Information
Table 134. BAG Healthcare Corporation Information
Table 135. BAG Healthcare Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. BAG Healthcare Main Product
Table 137. BAG Healthcare Recent Development
Table 138. BML Parenteral Drugs Large Volume Parenteral (LVP) Corporation Information
Table 139. BML Parenteral Drugs Corporation Information
Table 140. BML Parenteral Drugs Large Volume Parenteral (LVP) Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 141. BML Parenteral Drugs Main Product
Table 142. BML Parenteral Drugs Recent Development
Table 143. Sales Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. Large Volume Parenteral (LVP) Distributors List
Table 146. Large Volume Parenteral (LVP) Customers List
Table 147. Market Key Trends
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Global Large Volume Parenteral (LVP) Sales (M Units) Forecast by Type (2021-2026)
Table 151. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Type (2021-2026)
Table 152. Global Large Volume Parenteral (LVP) Revenue (Million US$) Forecast by Type (2021-2026)
Table 153. Global Large Volume Parenteral (LVP) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 154. Global Large Volume Parenteral (LVP) Sales (M Units) Forecast by Application (2021-2026)
Table 155. Global Large Volume Parenteral (LVP) Revenue (Million US$) Forecast by Application (2021-2026)
Table 156. Global Large Volume Parenteral (LVP) Sales (M Units) Forecast by Region (2021-2026)
Table 157. Global Large Volume Parenteral (LVP) Sales Market Share Forecast by Region (2021-2026)
Table 158. Global Large Volume Parenteral (LVP) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 159. Global Large Volume Parenteral (LVP) Revenue Market Share Forecast by Region (2021-2026)
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Large Volume Parenteral (LVP)
Figure 2. Global Large Volume Parenteral (LVP) Sales Market Share by Type: 2020 VS 2026
Figure 3. Soft Bag LVP Product Picture
Figure 4. Plastic Bottle LVP Product Picture
Figure 5. Glass Bottle LVP Product Picture
Figure 6. Global Large Volume Parenteral (LVP) Consumption Market Share by Application: 2020 VS 2026
Figure 7. Basic Infusion
Figure 8. Therapeutic Infusion
Figure 9. Nutritious Infusion
Figure 10. Global Large Volume Parenteral (LVP) Market Size 2015-2026 (US$ Million)
Figure 11. Global Large Volume Parenteral (LVP) Sales Capacity (M Units) (2015-2026)
Figure 12. Global Large Volume Parenteral (LVP) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Large Volume Parenteral (LVP) Sales Share by Manufacturers in 2020
Figure 14. Global Large Volume Parenteral (LVP) Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Large Volume Parenteral (LVP) Revenue in 2019
Figure 16. Large Volume Parenteral (LVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Large Volume Parenteral (LVP) Sales Market Share by Region (2015-2020)
Figure 18. Global Large Volume Parenteral (LVP) Sales Market Share by Region in 2019
Figure 19. Global Large Volume Parenteral (LVP) Revenue Market Share by Region (2015-2020)
Figure 20. Global Large Volume Parenteral (LVP) Revenue Market Share by Region in 2019
Figure 21. North America Large Volume Parenteral (LVP) Sales Market Share by Country in 2019
Figure 22. North America Large Volume Parenteral (LVP) Revenue Market Share by Country in 2019
Figure 23. U.S. Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 24. U.S. Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 26. Canada Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Large Volume Parenteral (LVP) Sales Market Share by Country in 2019
Figure 28. Europe Large Volume Parenteral (LVP) Revenue Market Share by Country in 2019
Figure 29. Germany Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 30. Germany Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 32. France Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 34. U.K. Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 36. Italy Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 38. Russia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Large Volume Parenteral (LVP) Sales Market Share by Region in 2019
Figure 40. Asia Pacific Large Volume Parenteral (LVP) Revenue Market Share by Region in 2019
Figure 41. China Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 42. China Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 44. Japan Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 46. South Korea Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 48. India Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 50. Australia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 52. Taiwan Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 54. Indonesia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 56. Thailand Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 58. Malaysia Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 60. Philippines Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Large Volume Parenteral (LVP) Sales Growth Rate (2015-2020) (M Units)
Figure 62. Vietnam Large Volume Parenteral (LVP) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Large Volume Parenteral (LVP) Sales Market Share by Country in 2019
Figure 64. Latin America Large Volume Parenteral (LVP) Revenue Market Share by Country in 2019
Figure 65. Mexico Large Volume Paren
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs